STEP UP BONUS CERTIFICATE - SARTORIUS STEDIM BIO Stock

Certificat

L0UNB

FRBNPP06FQ19

Market Closed - Euronext Paris 02:31:24 2024-05-14 EDT
20.25 EUR +0.10% Intraday chart for STEP UP BONUS CERTIFICATE - SARTORIUS STEDIM BIO
Current month+0.60%
1 month-22.90%
Date Price Change Volume
24-05-14 20.25 +0.10% 2
24-05-13 20.23 -0.83% 83
24-05-10 20.4 -0.63% 89
24-05-09 20.53 +0.98% 85
24-05-08 20.33 -1.26% 84

Real-time Euronext Paris

Last update May 14, 2024 at 02:31 am

More quotes

Static data

Product typeCertificats Bonus
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer BNP Paribas BNP Paribas
L0UNB
ISINFRBNPP06FQ19
Date issued 2024-02-05
Strike 300
Maturity 2024-09-20 (130 Days)
Parity 10 : 1
Emission price 24.51
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 27.76
Lowest since issue 19.08

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
203.6 EUR
Average target price
251.3 EUR
Spread / Average Target
+23.44%
Consensus
  1. Stock Market
  2. Certificates
  3. L0UNB Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW